Stereotaxis, Inc. (NYSEAMERICAN:STXS - Free Report) - Research analysts at Roth Capital issued their Q2 2025 earnings per share estimates for Stereotaxis in a research report issued on Monday, May 13th. Roth Capital analyst J. Wittes expects that the company will post earnings of ($0.01) per share for the quarter. The consensus estimate for Stereotaxis' current full-year earnings is ($0.23) per share.
Stereotaxis (NYSEAMERICAN:STXS - Get Free Report) last posted its quarterly earnings data on Monday, March 4th. The company reported ($0.07) EPS for the quarter, hitting the consensus estimate of ($0.07). The company had revenue of $4.57 million during the quarter, compared to analyst estimates of $7.55 million. Stereotaxis had a negative net margin of 73.32% and a negative return on equity of 105.62%.
Other equities analysts have also issued research reports about the company. Roth Mkm restated a "buy" rating and set a $5.00 price target on shares of Stereotaxis in a research note on Tuesday, March 5th. Lake Street Capital boosted their price objective on shares of Stereotaxis from $3.00 to $4.00 and gave the stock a "buy" rating in a research note on Tuesday, March 5th.
Read Our Latest Report on Stereotaxis
Stereotaxis Stock Performance
Shares of NYSEAMERICAN:STXS remained flat at $2.09 on Wednesday. The stock had a trading volume of 449,699 shares, compared to its average volume of 307,982. The company has a market capitalization of $171.65 million, a P/E ratio of -7.74 and a beta of 1.37. Stereotaxis has a fifty-two week low of $1.33 and a fifty-two week high of $3.29.
Hedge Funds Weigh In On Stereotaxis
A number of institutional investors have recently modified their holdings of STXS. Lagoda Investment Management L.P. raised its position in shares of Stereotaxis by 5.7% in the third quarter. Lagoda Investment Management L.P. now owns 3,249,785 shares of the company's stock worth $5,135,000 after acquiring an additional 176,150 shares during the period. Vanguard Group Inc. raised its holdings in Stereotaxis by 7.7% in the 1st quarter. Vanguard Group Inc. now owns 2,613,966 shares of the company's stock worth $6,822,000 after purchasing an additional 187,437 shares during the period. Essex Investment Management Co. LLC boosted its position in Stereotaxis by 1.6% during the first quarter. Essex Investment Management Co. LLC now owns 1,193,989 shares of the company's stock worth $3,116,000 after purchasing an additional 18,311 shares in the last quarter. Kovack Advisors Inc. grew its holdings in Stereotaxis by 16.9% in the fourth quarter. Kovack Advisors Inc. now owns 224,400 shares of the company's stock valued at $393,000 after purchasing an additional 32,493 shares during the period. Finally, Independent Advisor Alliance grew its holdings in Stereotaxis by 67.6% in the fourth quarter. Independent Advisor Alliance now owns 169,805 shares of the company's stock valued at $297,000 after purchasing an additional 68,500 shares during the period. Hedge funds and other institutional investors own 45.35% of the company's stock.
Stereotaxis Company Profile
(
Get Free Report)
Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.
Further Reading
Before you consider Stereotaxis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stereotaxis wasn't on the list.
While Stereotaxis currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
